Cargando…
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study
Autores principales: | Robinson, Blaine W., Kairalla, John A., Devidas, Meenakshi, Carroll, Andrew J., Harvey, Richard C., Heerema, Nyla A., Willman, Cheryl L., Ball, Amanda R., Woods, Elliot C., Ballantyne, Nancy C., Urtishak, Karen A., Behm, Frederick G., Reaman, Gregory H., Hilden, Joanne M., Camitta, Bruce M., Winick, Naomi J., Pullen, Jeanette, Carroll, William L., Hunger, Stephen P., Dreyer, ZoAnn E., Felix, Carolyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543184/ https://www.ncbi.nlm.nih.gov/pubmed/36861410 http://dx.doi.org/10.3324/haematol.2022.281552 |
Ejemplares similares
-
Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial
por: Guest, Erin M., et al.
Publicado: (2022) -
Long-term Results Of the Pediatric Oncology Group Studies For Childhood Acute Lymphoblastic Leukemia 1984-2001: A Report From The Children’s Oncology Group
por: Salzer, Wanda L., et al.
Publicado: (2009) -
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
por: Urtishak, Karen A., et al.
Publicado: (2018) -
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
por: Burke, Michael J., et al.
Publicado: (2019) -
Biocontrol of Bacterial Fruit Blotch by Bacillus subtilis 9407 via Surfactin-Mediated Antibacterial Activity and Colonization
por: Fan, Haiyan, et al.
Publicado: (2017)